Max Healthcare Institute Ltd has reported financial results for the period ended March 31, 2021.
Financial Results (Q4 FY20-21) - QoQ Comparison
The company has reported total income of Rs.830.54 crores during the period ended March 31, 2021 as compared to Rs.835.12 crores during the period ended December 31, 2020.
The company has posted net profit / (loss) of Rs.69.69 crores for the period ended March 31, 2021 as against net profit / (loss) of Rs.90.36 crores for the period ended December 31, 2020.
The company has reported EPS of Rs.0.75 for the period ended March 31, 2021 as compared to Rs.1 for the period ended December 31, 2020.
|
Total Income | ₹ 830.54 crs | ₹ 835.12 crs | -0.55% |
Net Profit | ₹ 69.69 crs | ₹ 90.36 crs | -22.88% |
EPS | ₹ 0.75 | ₹ 1 | -25% |
Financial Results (Q4 FY20-21) - YoY ComparisonThe company has reported total income of Rs.830.54 crores during the period ended March 31, 2021 as compared to Rs.274.96 crores during the period ended March 31, 2020.
The company has posted net profit / (loss) of Rs.69.69 crores for the period ended March 31, 2021 as against net profit / (loss) of Rs.53.15 crores for the period ended March 31, 2020.
The company has reported EPS of Rs.0.75 for the period ended March 31, 2021 as compared to Rs.0.91 for the period ended March 31, 2020.
|
Total Income | ₹ 830.54 crs | ₹ 274.96 crs | 202.06% |
Net Profit | ₹ 69.69 crs | ₹ 53.15 crs | 31.12% |
EPS | ₹ 0.75 | ₹ 0.91 | -17.58% |
Financial Results (Year ended FY 20-21) - YoY ComparisonThe company has reported total income of Rs.2619.41 crores during the 12 months period ended March 31, 2021 as compared to Rs.1107.11 crores during the 12 months period ended March 31, 2020.
The company has posted net profit / (loss) of Rs.(137.55) crores for the 12 months period ended March 31, 2021 as against net profit / (loss) of Rs.58.99 crores for the 12 months period ended March 31, 2020.
The company has reported EPS of Rs.(1.59) for the 12 months period ended March 31, 2021 as compared to Rs.1.01 for the 12 months period ended March 31, 2020.
|
Total Income | ₹ 2619.41 crs | ₹ 1107.11 crs | 136.6% |
Net Profit | ₹ (137.55) crs | ₹ 58.99 crs | -333.18% |
EPS | ₹ (1.59) | ₹1.01 | -257.43% |
Announcing Q4 results, Abhay Soi, Chairman and MD, Max Healthcare Institute Ltd, commented, "Our Q4 results of INR 1,089 Cr of net revenue and INR 263 Cr of Operating EBITDA is an excellent performance for the second consecutive quarter with our best ever operating margin of 24.1%. With ample room to scale up existing occupancies and improved international revenue share post abatement of the second surge of COVID-19, Q4 results in a way indicate the trajectory our network is geared for in terms of future performance.
Overall, we closed FY21 with INR 3,629 Cr in net revenue and recorded the highest annual operating EBITDA of INR 636 crores, despite a challenging year due to COVID-19 pandemic. The QIP fortified our balance sheet for pursing inorganic growth.
Besides serving on the frontline on COVID-19, we operationalized one of the largest vaccination centers (at BLKMax Hospital) in the country spread over 1.65 acres in a matter of 48 hours in the National Capital. This center alone has a capacity to administer ~10,000 vaccines daily.
As we enter into the new fiscal year, I am confident to continue our robust performance and gain further traction as one of the most trusted healthcare service providers in India."
Source : Equity Bulls
Keywords